Dyne Therapeutics, Inc. DYN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -58.9%-3.2pp | -55.7%+5.0pp | -60.7%+0.7pp | -61.3%+2.7pp | -64%+24.0pp | |
| Return on invested capital | -188.2%+12.6pp | -200.8%+4.8pp | -205.6%+14.7pp | -220.3%-44.9pp | -175.4%— | |
| Liquidity | ||||||
| Current ratio | 19.9×-2.3× | 22.3×+8.8× | 13.5×-3.4× | 16.8×-3.5× | 20.4×+4.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.2× | 0×0.0× | |
| Valuation | ||||||
| Market capitalization | $2.99B-7.1% | $3.22B+79.0% | $1.8B+48.9% | $1.21B+2.1% | $1.18B-50.6% | |
| Price / book | 3.5×+0.1× | 3.3×+0.7× | 2.6×+0.5× | 2.1×+0.3× | 1.8×-2.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Dyne Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.